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1. Introduction 
The reactive arthritis (ReA) is an autoimmune disorder usually induced by the prior 
infection. Conjunctivitis, urethritis and arthritis emerging after the prior onset of diarrhea 
were first described by Stoll in 1776. In 1818, Benjamin Brodie described 5 cases of 
conjunctivitis, urethritis and arthritis with a history of venereal diseases. In 1916, Fiessinger 
and Leroy described 4 patients with an oculo-urethro-synovial syndrome following a 
diarrhea caused by Shigella. In the same year, Hans Reiter described a triad of symptoms: 
nongonococcal urethritis, conjunctivitis and arthritis suffered by a young officer with 
bloody diarrhea and linked these symptoms to the Treponema infection. Until modern 
times, many researchers used the term Reiter's syndrome for this triad of symptoms. In 
1969, the use of the term reactive arthritis (ReA) was proposed, and in 1977, following the 
disclosure of the war crimes committed by Hans Reiter, it was recommended not to use the 
name of Reiter's syndrome due to ethical reasons. Based on the analysis of the literature the 
proportion of authors who use Reiter's name to describe the syndrome has decreased from 
34% in 1998 to 18% in 2003 and to 9% in 2007 (Keyan & Rimar, 2008). 
Reactive arthritis belongs to a group of diseases known as autoimmune seronegative 
spondyloarthropathy that is associated with a high incidence of HLA antigen B 27. 
Reactive arthritis is a disease with diverse clinical manifestations affecting the peripheral 
joints, spine, skin, eyes, digestive and other systems. The variety of symptoms means that 
patients, especially in the initial stage of the disease, are treated by the specialists of other 
fields than rheumatology. 
2. Definition 
The reactive arthritis is an asymmetric, non septic inflammation of several joints, mainly of 
the lower limbs, associated with the occurrence of a change called "enthesitis" (inflammation 
of the tendon), preceded by an extraarticular manifestation and by a documented infection 
(with or without symptoms present) with: Salmonella, Campylobacter, Yersinia, Shigella 
flexneri, Chlamydia trachomatis, Chlamydia pneumoniae; rarely with: Clostridium difficile, 
Mycobacterium bovis BCG, Mycoplasma species (e.g. Ureoplasma urealyticum), and very 
rarely with: Giardia Cryptospotidium, Shigella sonnei, Chlamydia psitacci, Hafnia alvei, 
Vibrio parahaemolyticus or other microorganisms. The reactive arthritis often has an acute 
onset. ReA may also take an atypical course, as inflammation can affect a single joint only, 
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with the concurrent presence of classic symptoms preceded by the diarrhea or urethritis / 
cervicitis with no infection detected. 
3. Pathogenesis 
The key role in the pathogenesis of reactive arthritis is assigned to the presence of bacteria or 
their products in the joint structures and the local immune response to the bacterial 
antigens. The presence of Chlamydia trachomatis has been demonstrated not only in 
reactive arthritis, but also in the synovial fluid of approximately 30% of patients with 
undifferentiated arthritis of few joints (the same situation takes place in the case of 
Chlamydia pneumoniae). In the case of Enterobacteriaceae (with the exception of 
Campylobacter jejuni and Yersinia) PCR (Polymerase Chain Reaction) testing often reveals 
DNA of these bacteria in the articular structures, while the ribosomal RNA is detected in 
Yersinia infections. The Yersinia penetrate into the M cells of the Peyer’s patches, where the 
reaction between the invasive bacterial proteins and integrin SS1 takes place. Yersinia can be 
transferred by phagocytes through the mucosal barrier and enters into the joint via blood 
pathway. The lymph nodes may constitute a reservoir of live Yersinia bacteria for many 
months following the manifestation of the first symptoms of reactive arthritis, which leads 
to a high level of long-lasting antibodies against these bacteria, while only bacteria 
fragments are detected in the joints. 
The emergence of reactive arthritis following the infection with Yersinia can be attributed to 
the presence of the bacteria derived arthritogenic peptide, which epitope is presented to T-
cells by the phagocytes in the synovial tissue. The HLA B27 + T cells respond to the 60kDa 
heat shock protein epitope and beta-subunit of the Yersinia’s urease, which can be detected 
in the joint. The Yersinia infection may be persistent in the lymph nodes or in the mucosa 
and the bacteria can be transported to the joint by the monocytes (Gaston et al. 1999). A 
similar mechanism applies to the development of reactive arthritis induced by Salmonella, 
in which the persistent presence of the bacterial lipopolysaccharide (LPS) in the synovium 
has been demonstrated. 
In the case of Chlamydia trachomatis, which is an intracellular pathogen, the epithelial cells 
are the primary location of the bacterial colonization. Chlamydia trachomatis can later infect 
other types of cells such as macrophages and other phagocytic cells. 
A replication of Chlamydia trachomatis in monocytes leads to the recognition of the 
Chlamydia antigen and induces the process of complex forming with class I and II HLA 
antigens that are presented on the CD4+ and CD 8+ T cells. The persistence of Chlamydia 
trachomatis can be long standing, as it is confirmed by the presence of bacterial mRNA, 
rRNA and DNA (PCR detected) in the synovium and in the peripheral blood (Gerard et 
al.1998, Kuipers et al., 1998, Zeidler et al.2004). The persistence of the infection is probably 
aided by the state of imbalance between cytokines such as tumor necrosis factor-α (TNF-α) 
and interleukin-10 (IL-10) – this imbalance being confirmed in vivo. Th1 cytokines such as: 
interleukin-12 (IL-12), interferon-γ (IFN-γ) and tumor necrosis factor-α (TNF-α) participate 
in the elimination of bacteria. The reduction of the activity of these cytokines or increase in 
Th2/Th3 cytokine production (especially of IL-10) reduces the capability of bacteria 
elimination from the organism. In patients with persistent infection high levels of IL-10 in 
the intestine, urogenital and respiratory systems has been demonstrated (Yin et al.1997). 
IL-6, IL-1 beta and IL-17 and IL-21 (Singh et al. 2011) play the key role in the formation of 
synovitis in ReA. 
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An important role in the pathogenesis of reactive arthritis and other spondyloartroaties is 
assigned to HLA B27 antigen. According to the arthritogenic peptide theory, it is believed 
that certain subtypes of HLA-B27 containing unique amino acid may be associated with the 
bacterial arthritogenic peptide and can be recognized by CD8 + T cells. This causes the 
response to the bacterial peptide, autoreactivity of T lymphocytes which recognize this 
peptide similar to the host's and activated by the host's peptides in the joints. HLA-B 27 
antigens are present in high proportion of patients with ReA induced by: Shigella (80-90%) 
Yersinia (70-80%), Chlamydia (40-50%) and Salmonella (20-33%) (Nicholis 1975). According 
to the recently most popular ReA pathogenesis model, called "multi-hit theory” the 
activation of the immune response in the reactive arthritis and other spondyloartropathies is 
a result of many circumstances such as: the effect of bacterial arthritogenic products 
(including lipopolisaccharides), HLA B-27 antigen presence, the extension of bacteria 
elimination time and other genetic or biomechanical factors. It was also reported that there 
is a link between HLA B 51 antigen, not only with the Behcet's disease, but also with the 
ReA - in particular in Japanese population (Shimamoto et all 2000). In HLA B 27 antigen 
negative patients the presence of HLA B 7, Bw22,B40,B42, B60 antigens – cross-reactive with 
HLA B27 antigen - may be also found. 
4. Clinical symptoms 
4.1 The beginning of the disease 
The onset is preceded by the symptoms of infection manifesting themselves approximately 4 
weeks before the articular symptoms. In the case of Chlamydia trachomatis and Chlamydia 
pneumoniae the symptoms of infection can go unnoticed, since 70% of infections may be 
asymptomatic or proceed with minor symptoms only. Infection caused by Chlamydia 
trachomatis is characterized by the onset of disuric symptoms, urethritis, prostatitis in men 
and cervitis and / or adnexitis in women. Chlamydia pneumoniae infections usually lead to 
symptoms of upper respiratory tract infection, cough, pharyngitis, otitis media and sinusitis. 
In patients infected with Enterobacteriacae e.g Shigella a short episode of joint symptoms 
may precede the diarrhea. The abdominal pain in the case of Yersinia may be periodically 
recurrent with enlargement of abdominal lymph nodes and, in some cases, proceeds with 
appendicitis symptoms. As reactive arthritis is a systemic disease, it may manifest itself with 
the systemic illness symptoms such as malaise, weakness and fever.  
4.2 Symptoms of the musculoskeletal system 
Joint symptoms may vary, ranging from arthralgia to the severe inflammation of several 
joints. Typically inflammation of a single or asymmetric inflammation of several joints is 
observed. Most commonly the lower extremities joints, such as knees, ankle and foot joints 
are affected. Inflammation can affect the fingers (dactilitis). This condition is known as 
„sausage digit" and is attributed to the inflammatory changes in the articular capsule, 
tendon sheath, periarticular structures and periosteum of the bone. Inflammation of the 
sacroiliac or spine joints occurs in approximately 50% of patients, manifesting itself as an 
inflammatory back pain (IBP) with back stiffness and buttock pain. Recurrent arthritis 
occurs in about 15% of patients and affects mainly patients with reactive arthritis with a 
history of Chlamydia infection. Inflammation of the tendon (enthesitis) is a common 
symptom of reactive arthritis. Very characteristic and helpful in identifying the enthesitis 
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are changes involving the attachments of the bottom surface of the calcaneus, Achilles 
tendon and plantar attachments - resulting in heel pain and difficulty in walking.  
4.3 Changes in skin and mucosa  
Inflammation of the mucous membrane of the urogenital tract manifests through the 
symptoms of urethritis /cystitis and cervitis/ colpitis. In some patients changes may involve 
the genitals beginning with the vesicular lesions evolving into erosion lesions or macular 
lesions. These affect the external opening of the urethra, glans and shaft of the penis and 
may precede joint symptoms. The described changes are referred to as ”balanitis circinata" 
(serpiginous annular dermatitis of the penis). These changes are painless unless subject to 
secondary infection and after treatment and recovery leave no scars. In women annular 
changes in the external genital organs are rare and are called “circinate vulvitis”. 
In reactive arthritis, various changes in the oral cavity may appear, such as painless, shiny 
aphthae on the palate, tongue or on the mucosa of the cheeks and mouth. Delicate red spots 
may also rarely occur in the palatal tonsils and lingula. Skin lesions in the course of reactive 
arthritis may be characteristic of this disease and are referred to as "keratoderma 
blenorrhagica." There are characteristic maculopapular scaly patches with excessive 
keratosis occurring on the plantar skin of the feet. They may also appear on the big toe, toes 
and hands. They appear less commonly on the scrotum, penis, trunk and scalp. 
Histologically, these changes are identical to psoriatic. Often changes called "palmoplantaris 
pustulosis"(pustular inflammation of the planta and hands) are observed occurring on the 
plantar side of hands and feet. Changes in nails occur mainly in chronic reactive arthritis, as 
yellowish or gray discoloration of the nails, bumps, hollow lines and nail keratosis are 
observed. “Thimble-pitting” of the nails, characteristic of psoriasis, is rarely observed. 
Although erythema nodosum often occurs post Yersinia infection, it is not associated with 
the course of reactive arthritis and has no connection with the presence of HLA-B27 antigen. 
4.4 Symptoms concerning the urogenital tract 
In addition to the above described inflammatory changes affecting the mucous membrane of 
the urogenital tract and the skin of sex organs, pathologies of the urinary system in course of 
ReA may include prostatitis, testitis and / or epididymitis in men and cervicitis and 
adnexitis in women (both being often asymptomatic in women and diagnosed incidentally 
during a pelvic gynecological control). Proteinuria caused by IgA nephropathy and 
amyloidosis due to chronic ReA may also occur, as well as cases of microhaematuria. 
Pyuria is observed in patients with sexually acquired reactive arthritis (SARA) mainly and 
occurs usually in Chlamydia trachomatis infections (42-69% of SARA cases), but also in 
Ureaplasma urealiticum, Gardnerella vaginalis and rarely in recurrent E. coli infections. 
 Symptoms associated with urinary tract are usually asymptomatic. 
4.5 Ocular changes 
 
 
Uveitis Scleritis Conjuntivitis 
Common - mainly anterior 
(AU) 
Rare Keratitis; rare 
Table 1. Eye involvement in reactive arthritis.  
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4.5.1 Conjunctivitis 
Conjunctivitis can occur in all types of reactive arthritis, often as an early symptom. It is 
predominant pathology of the sight organ in reactive arthritis and especially in patients with 
reactive arthritis caused by Chlamydia. Conjunctivitis affects 1 in 3 patients with ReA caused 
by Chlamydia, but it can also be observed in reactive arthritis resulting from Enterobacteriacae 
infection (usually post Shigella, Salmonella and Campylobacter infections, while only in 10% 
of Yersinia cases patients suffer from conjunctivitis). Symptoms can be bilateral, mild and 
progressive. In Chlamydia trachomatis induced reactive arthritis conjunctivitis occurs within a 
few days of the first symptoms of urethritis and usually withdraws within a week. 
Conjunctivitis can relapse and take a severe course. Conjunctivitis is often painless and non-
septic, but it may also cause burning sensation and irritation of the eyes. In the initial period of 
ReA conjunctivitis is observed in 2% of patients and in 96% patients with the chronic ReA. 
4.5.2 Uveitis 
In 10 to 20% of reactive arthritis patients with the HLA-B27 antigen present, one or more 
episodes of acute anterior uveitis occur. The main symptoms present are unilateral eye pain 
with redness, lacrimation, photophobia, and blurred vision. 13% of patients hospitalized in 
ophthalmology departments due to uveitis reveal spondyloarthropathies, with 7.2% 
diagnosed with reactive arthritis and 5.5% with ankylosing spondylitis.  
There are case reports of posterior uveitis involving choroid and retina in ReA. The macular 
degeneration of retina was also described in literature as emerging during post-dysenteria 
reactive arthritis (Sawhney, Parihar 2006).  
Scleritis is rare in patients with ReA but most common in other rheumatic diseases like 
rheumatoid arthritis. 
 
Anterior uveitis 
Iritis/irydocyclitis 
Intermediate uveitis 
Vitreous humor 
Posterior uveitis 
Choroid and retina 
Acute, unilateral 
Incidous onset,unilateral or 
bilateral 
Incidous onset 
red eye, pain , photophobia, 
visual loss (macular oedema) 
floaters, haziness of vision 
floaters, blurred vision, 
scotomata, visual loss 
Table 2. comparison of uveitis symptoms 
In chronic ReA with recurrent ocular symptoms anterior uveitis (92%) and posterior uveitis 
(64%) are frequently observed, as well as other ocular changes, such as keratitis (64%), 
cataract (56%), intermediate uveitis (40%), scleritis (28%), cystoid macular edema (28%), 
papillitis (16%) and glaucoma (16%) (Kiss et al.2003).  
4.6 Other symptoms 
Inflammatory changes in the aortic arch and ascending aorta and aortic valve regurgitation 
may also appear (Deer et al. 1991). 
5. Morphological changes 
5.1 Morphological changes in the joints 
The main change which occurs in the joints of reactive arthritis patients is an 
inflammation of the synovial tissue and presence of inflammatory fluid, leading to the 
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reduction of complement level in the joint due to local utilization of the complement. In 
the histological assessment the picture of the inflamed synovium is uncharacteristic and 
similar to other rheumatic diseases with synovitis. The microscopic examination reveals 
swelling, vascular lesions with infiltration of lymphocytes and granulocytes as well as 
plasma cells. In reactive arthritis, in contrast to the synovitis in rheumatoid arthritis, the 
emergence of pannus rarely takes place. The destructive changes of the bone are 
unspecific and occur only in patients with chronic inflammatory process. Another 
characteristic feature of reactive arthritis (as well as of other spondyloartropaties) is the 
infiltration of macrophages and lymphocytes in ligament trailers and bone tendons 
(enthesitis), bone resorption and its remodeling, resulting in subchondral hyperostosis 
and subperiosteal bone formation.  
5.2 Morphological changes in the skin and mucous membranes 
The skin lesions show infiltration of inflammatory cells such as lymphocytes and plasma 
cells, causing abnormal thickening and keratinization of the horny layer (stratum corneum), 
similar to psoriasis. The mucosal changes in the urogenital tract are similar, but keratosis is 
not observed.  
5.3 Morphological changes in the organ of sight 
In rheumatic diseases all anatomical parts of eye can be involved. In ReA conjunctiva , iris 
and cilliary body or both (anterior uveitis), vitreus body (intermediate uveitis), choroid 
and retina (posterior uveitis) are most commonly affected. ReA rarely concerns sclera 
(scleritis). In some cases of ReA panuveitis occurs. Changes in the eyes in the course of 
conjunctivitis are typical of follicular conjunctivitis and occur mainly in infection caused 
by Chlamydia, Salmonella, Shigella, Campylobacter and Yersinia. In Chlamydia infection 
, in case of direct autoinfections from the genitourinary tract, typical changes of yellow-
white papules (trachoma) frequently occur. Such changes are present in spite of 
Chlamydia trachomatis serotypes D-K being involved in the pathogenesis of ReA and not 
serotypes A-C responsible for trachoma forming. Recently, the contribution of Chlamydia 
trachomatis A-C serotypes to the pathogenesis of ReA with coexisting ocular symptoms 
has been demonstrated (Gerard et al.2010) as well as the simultaneous presence of chronic 
inflammatory changes in other tissues and organs.  
The histopathology assessment reveals the presence of the chronic inflammation cells 
localized in submucosal layer, with the predominance of lymphocytes. In addition, 
extensive fibrynogen deposits in the basal membrane of conjunctiva, infiltration of 
lymphocytes and macrophages around small blood vessels and lymphocytic infiltrate of the 
larger vessel walls of conjunctiva have been observed (Purcell & Tsai et al. 1982).  
In reactive arthritis, as in other spondyloarthropaties, anterior uveitis occurs. The incidence 
of anterior uveitis is more common than intermediate or posterior uveitis in ReA patients. 
The uveitis is more frequent in cases with HLA A-9 and HLA B 40 antigen presence than in 
cases in which HLA B 27 antigen is present.  
Pathomechanism of anterior uveitis development involves humoral and cellular response to 
retinal antigens (S-antigen) and to interphotoreceptor retinoid binding protein (IRBP) (De 
Smet et al. 1990). IRBP has been shown to induce posterior uveitis.  
The eye is considered as immunologically privileged organ. Some portions of the eye are 
avascular, and an immunosuppressive factors (such as TGF ß) are present in ocular fluids. In 
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some cases deviated regulation of the cellular response to the exogenous antigen in anterior 
chamber of the eye (anterior chamber associated immune deviation- ACAID) occurs. In 
ACAID phenomenon Ts lymphocytes impair the delayed hypersensitivity and complement 
dependent antibody production. This leads to suppressed cellular immunological response. 
The specifity of the eye immune environment is therefore important in immune and 
inflammatory diseases with eye involvement.( Wilbanks GA 1991).  
5.4 Morphological changes in the gastrointestinal tract 
In the course of reactive arthritis inflammatory bowel disease is observed. It concerns: the 
ileocecal valve area (22%), terminal ileum (12%) and the colon (3%). In 49% of cases 
abundant infiltration of inflammatory cells to the lining of the lamina propia of the 
mucosa is being observed along with the partial flattening of intestinal villi, hyperplasia 
of the cript epithelial cells, infiltration of cripts’ epithelium by neutrophils and cripts 
abscesses. In 18% erosions of intestinal epithelium with or without granuloma are present 
(Cuvelier et all, 1987).  
5.5 Morphological changes in the circulatory system 
The presence of inflammatory changes concerning the aortic arch and ascending aorta 
(aortitis) often leads to aorta enlargement and aortic valve regurgitation. 
6. Diagnostic criteria of reactive arthritis 
The reactive arthritis belongs to the spondyloarthropathies and thus must meet the 
classification criteria for this group of diseases, such as Amor criteria and criteria of the 
European Spondyloartrhopathy Study Group (ESSG). In 1996 during the Third International 
Workshop on Reactive Arthritis a group of experts proposed diagnostic criteria for ReA 
based on the presence of asymmetric peripheral arthritis (predominantly of the lower limbs) 
concomitant with evident prior infection and diarrhea or urethritis preceding by 4 weeks the 
emergence of the arthritis. In case of the lack of history of evident infection, the diagnosis 
should be confirmed after the exclusion of other diseases that cause inflammation of one or 
a few joints (Sieper et al.1999). 
There are no proper criteria for ReA recognition. ACR criteria for ReA diagnosis (1981) are 
defined as follows: an episode of arthritis lasting more than 1 month with concurrent 
urethritis and /or cervitis (84,3% of sensitivity and 98,2% specificity of diagnosis); episode of 
arthritis lasting more than 1 month and one of: urethritis or cervicitis, or bilateral 
conjunctivitis ( 85.5% of sensitivity and 96.4% of specificity); the episode of arthritis, 
conjunctivitis and urethritis with no time limits of the episode set (50.6% of sensitivity and 
98.8% of specificity ), an episode of arthritis lasting more than a month with conjunctivitis 
and urethritis (48.2% of sensitivity and 98.8% of specificity) [Willkens et al. 1981].  
7. Diagnostic tests in reactive arthritis 
There is no single diagnostic test to recognize ReA. Thus it is necessary for proper diagnosis to 
confirm previous infection and recognize characteristic symptoms of spondyloarthropathy 
such as e.g. enthesitis. It is also required to perform laboratory tests confirming the infection 
with one of the bacteria responsible for ReA induction. 
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7.1 Diagnosis of Chlamydia infection 
On the basis of serological tests it has been shown that Chlamydia trachomatis is a pathogen 
detected in 50% of ReA patients with a history of urinary tract infections, including 12-22% 
of cases in which the infection was asymptomatic. Often mixed infections of Chlamydia 
trachomatis, Chlamydia pneumoniae and Chlamydia psittaci takes place, being found in 
35% of patients with conjunctivitis (Dean et al.2008). ReA develops in 7-10% of patients 
infected with Chlamydia pneumoniae. Serological tests used to confirm Chlamydia 
trachomatis infections are often difficult to interpret, as they detect high levels of antibodies 
in healthy individuals and cross-react with Chlamydia pneumonia antibodies. Moreover, 
the diagnosis cannot be based on the presence of IgG antibodies, as they may persist for 
many months after the infection. Serological diagnosis should therefore be based also on the 
determination of IgM and IgA antibodies levels, which confirm acute or chronic infection. 
(Bas et al 1998) 
The Chlamydia infection can also be confirmed by DNA or RNA presence in urogenital 
system tested with PCR or LCR (ligand chain reaction). Another diagnostic possibility is 
detection of Chlamydia trachomatis DNA in synovial fluid.  
7.2 Diagnosis of infections of Yersinia, Salmonella, Campylobacter and Shigella 
Bacteriological stool examination in Yersinia and Salmonella induced ReA is useful only in 
case of coexisting diarrhea, as within 4 weeks of the onset of arthritis only in 9% of patients 
with previous diarrhea symptoms these tests yield positive results (Fendler et al. 2000). 
Diagnosis of these infections is based mainly on serological tests. In Yersinia-induced ReA 
IgG and IgA antibodies are found in 100% of patients. In 84% of ReA patients IgA antibodies 
against Yersinia antigen prevail from 14 up to 16 months from the first signs of infection and 
the increase in their level correlates with the exacerbation of arthritis. In patients with no 
arthritis, these antibodies disappear after 5 months. In patients with Yersinia-induced ReA 
as well as in patients with no arthritis, IgG antibodies may persist for a long time after the 
onset of the infection, but in patients with no arthritis coexisting IgA antibodies are not 
present. IgM antibodies persist in the body only from 1 to 3 months after the beginning of 
the infection. It is recommended, therefore, to determine the level of IgG, IgM and IgA 
antibodies in acute Re, while only the level of IgG and IgA antibodies should be determined 
in chronic ReA (Granfors et al. 1980). 
In Salmonella-induced ReA stool culture tests prove to be not very useful and yield positive 
results in only 4% of patients – both with and without persistent diarrhea. In Salmonella-
induced ReA all classes of antibodies may persist for a long time - from 9 to 14 months in 
serum (Maki-Ikola et al. 1991). Yersinia and Salmonella can survive in the body for many 
months and years (being detected in the peripheral blood), stimulating the production of 
antibodies IgA and / or IgM. The DNA of these bacteria is very rarely detected within the 
joint, which confirms that the mucosa and lymph nodes constitute reservoir for these 
organisms. Therefore the determination of bacterial DNA presence in the synovium or 
synovial fluid is irrelevant to ReA (Granfors et al. 1998). 
Currently a well-developed diagnostic methods for Campylobacter and Shigella infections 
do not exist. In the case of Campylobacter infections diagnosis can be based on 
bacteriological (in the presence of abdominal symptoms) or serological tests. For diagnosing 
infection, the presence of IgA antibodies has a greater specificity than presence of IgM 
antibodies (Locht & Krogfeld 2002). 
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7.3 Determination of the presence of HLA B27 antigen 
In case of symptoms which suggest ReA – and with the exclusion of other diagnosis – the 
determination of the HLA-B27 antigen presence increases the likelihood of correct diagnosis 
from 40 to 69%. The use of the serological methods and HLA-B27 typing increases the 
possibility of correct diagnosis to about 80% (Sieper et al.2002). 
8. Occurrence 
The ability of a proper assessment of the reactive arthritis incidence is limited due to: the 
lack of appropriate classification and diagnostic criteria, constant mobility of young people 
population and poor registration of venereal diseases as well as underdiagnosis of mild 
course ReA. Summary of data from various developing countries shows that the incidence 
of the reactive arthritis in the world is 100-200 per 100 000 inhabitants. Reactive arthritis is 
observed post Chlamydia trachomatis in 1-4 % of cases, while post Salmonella, Yersinia and 
Shigella infections it is observed in 2 - 4% of cases, with incidence growing to over 20% of 
patients with HLA-B27 antigen present. In the case of Campylobacterjejuni reactive arthritis 
develops in 1 - 5% of those infected. 
9. Physical examination 
It is necessary to control parameters of all vital signs. The physician performing the 
examination should pay particular attention for the signs of joint involvement (arthritis), 
skin and mucosal changes, eye involvement and symptoms suggesting lung pathologies 
(sarcoidosis).In case of patients presenting symptoms of the increased blood pressure or 
results of the urinanalysis deviated from the reference values, the renal involvement has 
to be considered. 
10. Ocular examination 
A basic observation may reveal red eye symptomatic for conjunctivitis, scleritis and uveitis 
anterior. Performing the direct ophtalmoscopy (fundoscopy) allows the detection of 
hyperemia of the conjunctiva adjacent to the cornea and the detection a hypopyon of the 
anterior chamber (inflammation in vitreous humor) - typical signs of an acute anterior 
uveitis. The direct ophtalmoscopy is also a basic examination in the case of the 
complications of uveitis, such as glaucoma or in case of any retinal changes.  
If the lens is clouded by a cataract, indirect ophtalmoscopy is a useful tool as it allows the 
better view of the fundus of the eye. 
Slit lamp examination is very important method for the evaluation of changes in the 
course of uveitis. This test allows assessment of iris stroma for formation of ulcers and 
edema, and corneal epithelium for abrasions, edema, ulcers and foreign bodies. Slit lamp 
findings can reveal presence of cells (leukocyte clumps) and flare (haze) in anterior 
chamber (evidence of protein presence) and posterior synechiae. In intermediate and 
posterior uveitis slit lamp examination can detect the condensations of the vitreous 
inflammatory cells occuring over the pars plana and ora serrata, forming “snowballs” and 
neovasularisation of the retinal periphery.  
Of other methods used in ocular examination, ocular coherence tomography (OCT) is used 
in detection of cystoid macular edema in uveitis (CMO) and fluorescein angiography is 
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useful in diagnosis of uveitis with macular oedema and in vasculitis. To control intraocular 
pressure in patient with uveitis, tonometry is used. 
In cases of eye pain and suspicion of sinusitis the nasoscopy and bacteriological exam of the 
nasal secretions are indicated. 
11. Results of laboratory tests 
The laboratory test results are nonspecific for the ReA and thus not useful to confirm the 
diagnosis, yet necessary to monitor the course of the disease. The deviations from the norm 
include: normocytic anemia, moderate leukocytosis with an increase in the number of 
neutrophils, the increase of ESR and CRP values. In general, urine test can reveal sterile 
pyuria with concomitant urethritis present. Antinuclear antibodies and rheumatoid factor 
are not present. An examination of the synovial fluid shows changes non-specific to the ReA 
with inflammatory fluid characteristic for other arthritis types as well. Synovial fluid is 
sterile without crystal presence. Synovial biopsy is nondiagnostic and shows inflammatory 
changes as in other arthritis. 
In some cases carrying out a differential diagnosis employing serology methods to exclude 
other infections - viral e.g. HIV or bacterial e.g. borrelia burgdorferi - is necessary. TPHA 
test is used for exclusion of syphilis, while the serum Angiotensin Converting Enzyme 
Assay (ACE) is used in cases of suspected sarcoidosis. 
12. ECG 
ECG changes occur in 5 - 14% of patients with chronic ReA and most of these changes take 
the form of prolonged PQ segment of I- degree AV block type. 
13. X-ray examinations 
Radiographic changes are seen in more than 70% of patients with chronic reactive arthritis 
and are characterized by the picture of swelling soft tissues (especially characteristic is so-
called "sausage finger"), periosteal ossification with exostosis, erosions on the articular 
surfaces and periarticular osteopenia. Less frequently erosions in small joints of the feet, 
hands, knees and sacroiliac joints are observed. The presence of enthesitis can be 
demonstrated on x-ray, tough ultrasound examination can reveal a much earlier stages of 
the erosions. In the reactive arthritis, bone proliferation develops in many places, including 
the periosteum and takes a linear or feathery arrangement adhering to the cortical edge, 
particularly along the shaft of the metacarpal and metatarsal bones, toes, distal femoral end 
and the ankle. Smilar changes are seen in calcaneal, ischial and femoral trochanter tendon 
attachments, giving a picture of feathery ossifications. The presence of enthesitis changes 
may suggest reactive arthritis, but cannot determine the diagnosis, because such changes 
may occur in other diseases (sensitivity of 30%). Radiographic evidence of the spine in 
reactive arthritis is associated with disease duration and its nature. 50% of patients with 
chronic reactive arthritis have radiographic evidence of sacroilitis. Sacroilitis is observed 
more frequently in patients with Chlamydia trachomatis induced reactive arthritis (32%). 
Erosions are most often observed at the hip bone. In the later course of the disease pseudo-
dilatation of the joint, bone proliferation, sclerosis and ankylosis are observed (Martel et 
al.1979, Colmegna et al. 2004). 
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Chest x-ray is important in suspected tuberculosis or sarcoidosis and with other cases with 
symptoms of respiratory tract involvement. In some cases a hight resolution CT scan chest is 
needed. 
14. Differential diagnosis 
14.1 Arthritis 
The differential diagnosis of reactive arthritis should be based on the exclusion of other 
causes of arthritis, including other forms of spondyloarthropathies, arthritis in the course of 
other rheumatic diseaseas, systemic diseases, such as cancer, post-infectious arthritis e.g. in 
Lyme disease or in the course of viral or streptococcal infections. Changes of enthesopathy -
type, which are typical of reactive arthritis, may also occur in other spondyloarthropaties 
and other rheumatic diseases. 
14.2 Differential diagnosis in patients with ReA and eye involvement  
 
 
Anterior uveitis 
Idiophatic anterior uveitis 
Spondyloarthropaties other than ReA 
Sarcoidosis 
Juvenile idiopathioc arthritis 
Behcet disease 
Relapsing polychondritis 
Vasculitis (Cogan syndrome, Kawasaki disease, Wegeners’ syndrome) 
SLE 
Sjogren syndrome 
Infections (Whipple disease, Lyme disease) 
Others eg. Sweets’ syndrome 
Familal granulomatous synovitis 
Neonatal onset multisystem inflammatory 
Posterior uveitis 
Sarcoidosis  
Eale’s disease 
Bridshot choirodoretinopathy 
Behcet disease 
CMV  
Toxoplasmosis  
Herpes infection 
Tuberculosis 
Histoplasmosis  
Syphilis 
Table 3. Examples of the diseases in differentiation of uveitis (Enzenauer Sterling G.West 
2002) 
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15. The course of the disease 
The duration of reactive arthritis is considered to be chronic when it extends over 6 
months (Braun et al. 2000). As many as 75% of ReA patients achieve complete remission 
within one year of the first symptoms and in 15% of patients the disease becomes a 
chronic spondyloarthropathy. The chronic ReA is induced by: Yersinia - 4%, Salmonella – 
19%, Shigella – 19% and Chlamydia – 17% (Leirisalo-Repo et al. 1997, Leirisalo-Repo, 
1998). Sacroiliitis is reported in 14-49% of patients, while 12% to 26% of patients with ReA 
develop ankylosing spondylitis (van der Linden, 2000). In patients with no negative 
prognostic features the course of the disease can lead to spontaneous recovery or is 
usually benign. 
16. Prognosis 
The course of the reactive arthritis depends on the type of inducing bacteria, the presence 
of HLA-B27 antigen, gender and recurrence of arthritis. The worst prognosis is in 
Chlamydia induced reactive arthritis. Recovery occurs only in 30% of cases, joint pain 
persists in 68% of patients, recurrent arthritis occurs in 68% of patients, changes in the 
sacroiliiac joints are found in 49% of patients and 26% of patients develop AS - ankylosing 
spondylitis (Leirisalo-repo 1998, Inman 2000). Patients with HLA-B27 antigen presence 
have more severe course of the disease, more frequently sacroiliac joints are involved and 
more frequently the disease manifests itself in other organs. Male gender, positive family 
history of occurrence of spondyloarthropathies (including AS) and the presence of 
inflammation of the hip are also negative prognostic factors. In these patients the 
inflammation of the spine, destructive changes in the hip and the involvement of 
sacroiliac joints are frequent. In the first 2 years of the disease an elevated ESR (> 30 mm 
after 1 h), the lack of improvement after non-steroidal anti-inflammatory drugs, 
inflammation of the hip, reduction in spinal mobility, the occurrence of “sausage finger” 
in the feet, inflammation of several joints and the onset of the disease before the age of 16 
– all are considered to be negative prognostic factors (Kelley et al. 2001). 
Patients with eye involvement in chronic ReA may develop ocular complications such as: 
secondary cataract and glaucoma, cystoid macular oedema (CMO), impairment of visulal 
function (to the extent of the complete blindness).  
17. Treatment 
17.1 Treatment of extraarticular changes 
The extraarticular changes should be treated in parallel with general treatment of the 
disease carried out by the specialists in proper field of medicine. 
17.1.1 Ocular symptoms 
Aims of treatment include: pain relief and easing photophobia, elimination of inflammation, 
prevention of complications and preservation of proper visual function (Agrawal, 2010). 
Conjunctivitis in reactive arthritis should be treated with locally administered antibiotics. In 
Chlamydia infection the local antibiotic therapy should be simultaneous with general 
antibiotic therapy. It is recommended to use topical 1% azithromycyn in drops 2 - 3 times 
daily for 2 - 3 weeks or 0.5% erythromycin ointment 3-3 times daily for 2-3 weeks. 
Tetracycline and quinolones can also be used locally (Chen et al. 2010).  
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In anterior uveitis it is recommended to use corticosteroids locally in the form of eye drops 
or periocular injections or systemic administration, the latter in severe cases. Systemic 
Glucocorticosteroids can be used in the cases when the local treatment of uveitis is not 
sufficient or the diseases is recurrent and bilateral. In intermediate and posterior uveitis 
corticosteroids in subtenon’s injection may be administered. 
Drugs extending pupils (mydriatics) are recommended as well to relieve pain and prevent 
posterior synechiae. In the case of the eye being affected in the course of the ReA, it is 
sometimes necessary not only to use glucocorticosteroides and non-steroidal anti-
inflammatory drugs (NSAIDs), but also immunosuppressive agents like methotrexate , 
cyclosporine, azathiopryne . Immunosuppessive therapy is recommended in cases resistant 
to corticosteroids. In complications of uveitis e.g. cataract a surgery treatment should be 
considered. In cases of uveitis associated glaucoma the local or systemic antiglaucoma 
medications are used. 
In CMO the local administration of NSAIDs or corticoids in posterior subtenon’s injections 
may be employed. 
The lack of response to uveitis therapy implies that we might be dealing with the 
masquerade syndromes of diseases such as leukemia, lymphoma, retinoblastoma, malignant 
melanoma, antiphospholipid syndrome and thus these illnesses should be excluded. 
17.1.2 Skin lesions  
Skin lesions in the course of reactive arthritis can be treated locally with keratolytic agents 
(e.g. used locally with salicylates), corticosteroids or calcipotriol in the form of cream or 
ointment. Balanitis circinata may be treated with corticosteroids such as Hydrocortisone 
ointment. 
17.2 Treatment of arthritis and tendon attachments 
17.2.1 General recommendations for treatment of reactive arthritis 
In patients with reactive arthritis the limitation of physical activity is recommended, 
especially walking in cases with lower limbs joints affected. It is important to use physio- 
and kinesitherapy, together with pharmacological treatment. The treatment of reactive 
arthritis should be based on reducing pain, anti-inflammatory treatment and – if possible – 
on the infection eradication. 
17.2.2 Non-steroidal anti-inflammatory drugs 
The use of NSAIDs is a basic therapy in the initial diagnostic period, while prolonged 
therapy with these drugs is recommended only in cases with persistent inflammation. 20-
25% of patients with reactive arthritis do not feel improvement after non-steroidal anti-
inflammatory drugs. 
17.2.3 Glucocorticoids 
The use of glucocorticoids is recommended intraarticularly only (after excluding purulent 
arthritis), with such administration reducing the symptoms of synovitis. Oral systemic 
glucocorticoid treatment may prolong the elimination of the infection, while it does not 
affect clinical and laboratory activity of the disease. There have been no studies so far 
assessing the indication for the use of steroids in high dose intravenous injections (pulses) in 
reactive arthritis. 
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17.2.4 Disease-modifying drugs 
In case of ineffectiveness of NSAIDs in ReA the use of disease-modifying drugs is 
recommended. The most commonly used drugs in this group include sulfasalazine, 
methotrexate, azathioprine, cyclosporine, leflunomide. 
The use of sulfasalazine in 2g/24 hours dose is very effective in reactive arthritis in case of 
concomitant mucositis. 
Sulfasalazine presents some antibacterial activity as well (Egsmose et al. 1997), being quite 
effective and well tolerated (Clegg et al.1996). Comparative studies have demonstrated 
greater efficacy of sulfasalazine in the treatment of peripheral joint involvement in reactive 
arthritis than in the treatment of ReA axial involvement form (Clegg et al. 1999). 
Methotrexate treatment is also very effective in ReA, although there are no randomized 
studies to evaluate its effectiveness. It has been demonstrated however, that in patients with 
arthritis of the spine joints the methotrexate treatment prevents the emergence of the 
ossification of the spine and of the erosive lesions of peripheral joints (Ritchelin et al. 2001). 
Azathioprine, in dose of 1 - 2 mg / kg of body weight, is effective in the treatment of ReA 
with peripheral joint involvement (Calin1986). 
17.2.5 Biological treatment 
There are no randomized trials evaluating the efficacy and safety of biological agents of anti-
TNF-alpha group in the treatment of ReA. Individual publications about etanercept and 
infliximab treatment in ReA point to high efficacy of these drugs (Abdelmoulaet al.2008, 
Gill et al. 2008, Schafranski 2009, Flagg et al.2005). The use of biological agents from the 
anti-TNF-alpha group is restricted to the chronic form of the disease, in which disease-
modifying drugs were ineffective. Such restriction in use of agents result from the risk of 
extending the latent infection and Chlamydia and Yersinia, associated with the 
administration of these drugs. 
17.2.6 Antibiotic therapy 
The use of antibiotics in reactive arthritis still raises controversy. Eradication of bacteria 
causing reactive arthritis should improve prognosis or prevent the development of reactive 
arthritis. Studies have shown various effects of antibiotic use for ReA induced by 
genitourinary infections and different effects in Enterobacteriacae-induced ReA cases. 
17.2.6.1 The use of antibiotics in Chlamydia-induced ReA 
A study performed on the Greenland population, in which the high incidence of HLA-B27 
antigen exists, showed that the use of antibiotics in genitourinary tract infections of 
patients with HLA B-27 antigen significantly reduces the number of patients who develop 
ReA - from 37% to 10% (Bardin, 1992). It was also shown that it is vital that the sexual 
partner of a person who has Chlamydia infection is treated in parallel with the patient. 
Another study documented the use of limecycline for 3 months in patients with acute 
Chlamydia-induced ReA, revealing a beneficial therapeutic effect on arthritis, with an ESR 
reduction and normalization of C reactive protein (CRP) levels in the group treated with 
antibiotic (Lauhio et al. 1991). 
Good results of application of tetracycline or ciprofloxacin for a period from 4 to 12 weeks in 
acute Chlamydia-induced ReA were also reported (Schumacher et al. 1999). Recent in vitro 
studies showed high efficacy of using a combination of antibiotics (azithromycin + 
rifampicin) in eradicating Chlamydia infection (Dreses-Werringloer et al.2001), later 
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confirmed in clinical studies performed with rifampicin and doxycycline (Carter et al. 2004). 
The therapy with rifampicin and azithromycin has been demonstrated in experimental 
studies to be very effective in the eradication of chronic Chlamydia pneumoniae infection 
(Bin et al. 2000). Eradication of Chlamydia infections affects the further course of chronic 
ReA, resulting in reducing inflammatory activity and pain. In some cases such treatment 
leads to complete remission. 
17.2.6.2 The use of antibiotics in the Enterobacteriacae induced ReA 
The use of antibiotics in the Enterobacteriaceae-induced ReA raises a lot of controversy. 
Many studies have shown no effect of antibiotic therapy used in acute or chronic ReA on the 
course of the disease (Sieper et al. 1999, Toivanen 2000, Yli-Kerttula, 2000). On the other 
hand 4-7 year-long observations of patients with Enterobacteriacae induced ReA treated 
with three-months course of ciprofloxacin revealed the influence of the therapy on the 
distant course of ReA, particularly in patients with HLA B-27 antigen and may prevent the 
development of chronic ReA (Yli-Kerttula, 2003). However, this requires further research. 
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